Latest News

Advion’s parent company Bohui Innovation Biotechnology will acquire Interchim group

Advion Inc. today announces parent company Beijing Bohui Innovation Biotechnology Co., Ltd., has filed its intention to acquire Adchim SAS, the parent company of the Interchim group companies.

Source link

Related posts

FDA and CBP collaborate to protect public health and safety


OncoImmunity erhält 2,2 Mio. Euro zur Einführung seiner Maschinenlernplattform für die Entwicklung von personalisierten Krebsimmuntherapien


Benzodiazepine Receptor Agonist – Pipeline Insight, 2019 –


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World